$3.00
+0.10 (+3.45%)
USD · as of 2026-08-18 · marketstack
Clinical trials
catalyst calendar across sponsors →Studies where SRTS is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.
3 observational · 1 with posted results
Held by 2 tracked-famous managers (RENAISSANCE TECHNOLOGIES LLC, JANE STREET GROUP, LLC) · FINRA short interest 10.2 days to cover (settled 2026-07-31) · government filings 180d: none disclosed
| Study | Phase | Status | Interventions | Conditions | Enrollment | Primary completion | Updated |
|---|---|---|---|---|---|---|---|
| Superficial Radiation Therapy (SRT) for the Treatment of Recurrent Keloid ScarsNCT04184011observationalIncidence of keloid recurrence rates. | — | Unknown status | Device: SRT-100™ | Keloid Scar | 100 | 2020-08-16 | 2019-12-03 |
| A Retrospective Evaluation of Superficial Radiation Therapy (SRT) and Non-Melanoma Skin Cancer (NMSC)NCT03693937results2019-07-05observationalCure RateStudy Protocol and Statistical Analysis Plan ↗ | — | Completed | Radiation: SRT-100 | Non-melanoma Skin Cancer | 776 | 2019-03-16actual | 2019-07-05 |
| A Retrospective Evaluation of Superficial Radiation Therapy (SRT) and Keloid Scars.NCT03693924observationalLong-term recurrence rate | — | Unknown status | Radiation: SRT-100 | Keloid Scar | 100 | 2019-02-16 | 2018-10-03 |
Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.
Source: ClinicalTrials.gov, retrieved 2026-08-19